Literature DB >> 9672148

Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17.

X Y Cai1, C P Gommoll, L Justice, S K Narula, J S Fine.   

Abstract

Interleukin-17 (IL-17) has been previously reported to induce stromal cells to produce a number of hematopoietic and proinflammatory cytokines, including granulocyte colony-stimulating factor (G-CSF). Here, we have evaluated the mechanisms responsible for the augmentation of G-CSF gene expression by IL-17, using the murine 3T3 fibroblast cell line. Treatment of 3T3 cells, but not primary bone marrow-derived macrophages or murine monocyte/macrophage cell lines, resulted in increased steady-state G-CSF mRNA levels within 2-4 h and augmented G-CSF protein production. The combination of IL-17 and LPS enhanced G-CSF expression in an additive fashion. Stability studies revealed that IL-17 stabilized G-CSF mRNA levels, with a t1/2 of 4 h, compared to a t1/2 of less than 2 h in medium or LPS-treated cells. Induction of G-CSF expression in 3T3 cells by IL-17 did not appear to require tyrosine kinase activation or de novo protein synthesis. These studies indicate that post-transcriptional mechanisms play an important role in IL-17-induced G-CSF expression in fibroblasts and suggest that IL-17 may be useful for further delineating mechanisms of G-CSF gene regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672148     DOI: 10.1016/s0165-2478(98)00027-3

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  32 in total

Review 1.  Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion.

Authors:  Sheinei J Saleem; Daniel H Conrad
Journal:  Int Immunopharmacol       Date:  2011-03-21       Impact factor: 4.932

2.  Th17 cells in inflammatory conditions.

Authors:  Anne Cooke
Journal:  Rev Diabet Stud       Date:  2006-08-10

Review 3.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

4.  Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1.

Authors:  Sonam Dhamija; Reinhard Winzen; Anneke Doerrie; Gesine Behrens; Nancy Kuehne; Celina Schauerte; Elena Neumann; Oliver Dittrich-Breiholz; Michael Kracht; Helmut Holtmann
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

5.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

6.  Anti-inflammatory role of IL-17 in experimental autoimmune uveitis.

Authors:  Yan Ke; Ke Liu; Guo-Qiang Huang; Yan Cui; Henry J Kaplan; Hui Shao; Deming Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 7.  Interleukin-17 and systemic lupus erythematosus: current concepts.

Authors:  A Nalbandian; J C Crispín; G C Tsokos
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 8.  Th17 cytokines and the gut mucosal barrier.

Authors:  Christoph Blaschitz; Manuela Raffatellu
Journal:  J Clin Immunol       Date:  2010-02-02       Impact factor: 8.317

Review 9.  IL-17 in systemic lupus erythematosus.

Authors:  José C Crispín; George C Tsokos
Journal:  J Biomed Biotechnol       Date:  2010-04-06

Review 10.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.